Béné MC - Search Results

1

Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration*.

Guérin E, Orabona M, Raquil MA, Giraudeau B, Bellier R, Gibot S, Béné MC, Lacombe F, Droin N, Solary E, Vignon P, Feuillard J, François B. Guérin E, et al. Among authors: bene mc. Crit Care Med. 2014 Sep;42(9):2007-18. doi: 10.1097/CCM.0000000000000344. Crit Care Med. 2014. PMID: 24942511

2

Immunologic analysis of a thousand cases of acute leukemia. French Groupe d'Etude Immunologique des Leucémies (GEIL).

Béné MC, Boumsell L, Vannier JP, Garand R, Solary E, Faure G, Bernard A. Béné MC, et al. Nouv Rev Fr Hematol (1978). 1989;31(2):133-6. Nouv Rev Fr Hematol (1978). 1989. PMID: 2671926 Clinical Trial.

3

Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia.

Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Gibot S, et al. Among authors: bene mc. N Engl J Med. 2004 Jan 29;350(5):451-8. doi: 10.1056/NEJMoa031544. N Engl J Med. 2004. PMID: 14749453 Free article.

4

Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock.

Gibot S, Le Renard PE, Bollaert PE, Kolopp-Sarda MN, Béné MC, Faure GC, Lévy B. Gibot S, et al. Among authors: bene mc. Intensive Care Med. 2005 Apr;31(4):594-7. doi: 10.1007/s00134-005-2572-x. Epub 2005 Mar 8. Intensive Care Med. 2005. PMID: 15754199

5

Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis.

Gibot S, Cravoisy A, Kolopp-Sarda MN, Béné MC, Faure G, Bollaert PE, Levy B. Gibot S, et al. Among authors: bene mc. Crit Care Med. 2005 Apr;33(4):792-6. doi: 10.1097/01.ccm.0000159089.16462.4a. Crit Care Med. 2005. PMID: 15818107 Clinical Trial.

6

Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats.

Gibot S, Alauzet C, Massin F, Sennoune N, Faure GC, Béné MC, Lozniewski A, Bollaert PE, Lévy B. Gibot S, et al. Among authors: bene mc. J Infect Dis. 2006 Oct 1;194(7):975-83. doi: 10.1086/506950. Epub 2006 Aug 29. J Infect Dis. 2006. PMID: 16960786

7

Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study.

Lacombe F, Arnoulet C, Maynadié M, Lippert E, Luquet I, Pigneux A, Vey N, Casasnovas O, Witz F, Béné MC. Lacombe F, et al. Among authors: bene mc. Leukemia. 2009 Feb;23(2):350-7. doi: 10.1038/leu.2008.296. Epub 2008 Nov 6. Leukemia. 2009. PMID: 18987664

8

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Garnache-Ottou F, Vidal C, Biichlé S, Renosi F, Poret E, Pagadoy M, Desmarets M, Roggy A, Seilles E, Soret L, Schillinger F, Puyraimond S, Petrella T, Preudhomme C, Roumier C, MacIntyre EA, Harrivel V, Desbrosses Y, Gruson B, Geneviève F, Thepot S, Drebit Y, Leguay T, Gros FX, Lechevalier N, Saussoy P, Salaun V, Cornet E, Benseddik Z, Veyrat-Masson R, Wagner-Ballon O, Salanoubat C, Maynadié M, Guy J, Caillot D, Jacob MC, Cahn JY, Gressin R, Rose J, Quesnel B, Guerin E, Trimoreau F, Feuillard J, Gourin MP, Plesa A, Baseggio L, Arnoux I, Vey N, Blaise D, Lacroix R, Arnoulet C, Benet B, Dorvaux V, Bret C, Drenou B, Debliquis A, Latger-Cannard V, Bonmati C, Bene MC, Peterlin P, Ticchioni M, Rohrlich PS, Arnaud A, Wickenhauser S, Bardet V, Brechignac S, Papoular B, Raggueneau V, Vargaftig J, Letestu R, Lusina D, Braun T, Foissaud V, Tamburini J, Bennani H, Freynet N, Cordonnier C, Le Garff-Tavernier M, Jacques N, Maloum K, Roos-Weil D, Bouscary D, Asnafi V, Lhermitte L, Suarez F, Lengline E, Féger F, Battipaglia G, Mohty M, Bouyer S, Ghoual O, Dindinaud E, Basle C, Puyade M, Lafon C, Fest T, Roussel M, Cahu X, Bera E, Daliphard S, Jardin F, Campos L, Solly F, Guyotat D, Galoisy … See abstract for full author list ➔ Garnache-Ottou F, et al. Among authors: bene mc. Blood Adv. 2019 Dec 23;3(24):4238-4251. doi: 10.1182/bloodadvances.2019000647. Blood Adv. 2019. PMID: 31869411 Free PMC article.

9

Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).

Solary E, Casasnovas RO, Campos L, Béné MC, Faure G, Maingon P, Falkenrodt A, Lenormand B, Genetet N. Solary E, et al. Among authors: bene mc. Leukemia. 1992 May;6(5):393-9. Leukemia. 1992. PMID: 1375696

10

Prognostic relevance of surface markers in adult de novo acute myeloblastic leukemias: a prospective study of the Groupe d'Etude Immunologique des Leucémies (G.E.I.L.).

Casasnovas RO, Solary E, Campos L, Maynadie M, Favre M, Bremend JL, Garand R, Béné MC, Faure G. Casasnovas RO, et al. Among authors: bene mc. Leuk Lymphoma. 1994;13 Suppl 1:7-10. doi: 10.3109/10428199409052665. Leuk Lymphoma. 1994. PMID: 8075584 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

578 results

Search Page

Filters